Cervical cancer, one of the most common gynaecological cancers, is the consequence of persistent infection by the human papillomavirus family.This article is an authoritative review on the subject, by Professor IH Frazer, internationally acclaimed for his work on the development of the world’s first cervical cancer vaccine.
Get full access to this article
View all access options for this article.
References
1.
ParkinDM.The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118(12):3030–44.
2.
KoshiolJEJCSchroederJamiesonDJ Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer 2006; 119(7):1623–9.
3.
FrazerI.God’s gift to women: the human papillomavirus vaccine. Immunity 2006; 25(2):179-84.
4.
LowyDRSchillerJT.Prophylactic human papillomavirus vaccines. J Clin Invest 2006; 116(5):1167–73.
5.
JA Kahn, RD Burk. Papillomavirus vaccines in perspective. Lancet 2007; 369(9580):2135–7.
